{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:54:30Z","timestamp":1788310470055,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ghir.2022.101484","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:50:04Z","timestamp":1656593404000},"page":"101484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study"],"prefix":"10.1016","volume":"66","author":[{"given":"Cem","family":"Sulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayyuce Begum","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman Sami","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubilay","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ghir.2022.101484_bb0005","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr. Rev."},{"issue":"11\/12","key":"10.1016\/j.ghir.2022.101484_bb0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2004-814150","article-title":"Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications","volume":"35","author":"Renehan","year":"2003","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.ghir.2022.101484_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ghir.2022.101484_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2014","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.ghir.2022.101484_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2008.0062","article-title":"Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma","volume":"7","author":"Rezz\u00f3nico","year":"2009","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"5","key":"10.1016\/j.ghir.2022.101484_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127276","article-title":"The role of diabetes in acromegaly associated neoplasia","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2013.02.038","article-title":"Metformin and cancer","volume":"705","author":"Rizos","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.ghir.2022.101484_bb0060","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16556","article-title":"Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells","volume":"8","author":"An","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ghir.2022.101484_bb0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ghir.2022.101484_bb0070","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/EJE-13-1031","article-title":"Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies","volume":"170","author":"Raverot","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2022.101484_bb0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1089\/thy.2017.0550","article-title":"Protective effect of metformin against thyroid Cancer development: a population-based study in Korea","volume":"28","author":"Cho","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2022.101484_bb0080","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2022.101484_bb0090","series-title":"biostat3: utility functions, datasets and extended examples for survival analysis, R package version 0.1 4","author":"Karlsson","year":"2019"},{"key":"10.1016\/j.ghir.2022.101484_bb0095","author":"Carstensen","year":"2022","journal-title":"Package \u2018Epi\u2019"},{"issue":"6","key":"10.1016\/j.ghir.2022.101484_bb0100","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2017-02457","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3\u20134","key":"10.1016\/j.ghir.2022.101484_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000095531","article-title":"Cancers associated with acromegaly","volume":"83","author":"Jenkins","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2005.02316.x","article-title":"High prevalence of differentiated thyroid carcinoma in acromegaly","volume":"63","author":"Tita","year":"2005","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2022.101484_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/thy.2011.0173","article-title":"Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study","volume":"22","author":"Cl\u00e9ro","year":"2012","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ghir.2022.101484_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF03346519","article-title":"Current iodine status in Turkey","volume":"32","author":"Erdo\u011fan","year":"2009","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0130","first-page":"267","article-title":"Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster","volume":"37","author":"Ozdemir","year":"2012","journal-title":"Minerva Endocrinol."},{"issue":"9418","key":"10.1016\/j.ghir.2022.101484_bb0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nature metabolism"},{"issue":"9","key":"10.1016\/j.ghir.2022.101484_bb0145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0898-6568(01)00186-3","article-title":"Signal transduction via the growth hormone receptor","volume":"13","author":"Zhu","year":"2001","journal-title":"Cell. Signal."},{"issue":"02\/03","key":"10.1016\/j.ghir.2022.101484_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-978703","article-title":"Insulin and IGF-I receptors signaling in protection from apoptosis","volume":"31","author":"Prisco","year":"1999","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0303-7207(89)90199-8","article-title":"Evidence for autocrine production of IGF-1 in human thyroid adenomas","volume":"61","author":"Williams","year":"1989","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ije\/dyp186","article-title":"Cohort profile: the metabolic syndrome and Cancer project (me-can)","volume":"39","author":"Stocks","year":"2010","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ghir.2022.101484_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0180","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s12032-011-9846-7","article-title":"Metformin and cancer: new applications for an old drug","volume":"29","author":"Kourelis","year":"2012","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/REP-09-0351","article-title":"Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells","volume":"139","author":"Tosca","year":"2010","journal-title":"REPRODUCTION"},{"key":"10.1016\/j.ghir.2022.101484_bb0190","first-page":"1","article-title":"The prevalence of secondary neoplasms in acromegalic patients: possible preventive and\/or protective role of metformin","author":"Costa","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2022.101484_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mce.2014.05.021","article-title":"Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo","volume":"393","author":"Cho","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ghir.2022.101484_bb0205","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ghir.2022.101484_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109852","article-title":"Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes","volume":"9","author":"Tseng","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0215","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/jc.2015-3901","article-title":"Diabetes, diabetes treatment, and risk of thyroid cancer","volume":"101","author":"Luo","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.ghir.2022.101484_bb0220","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s12885-015-1719-6","article-title":"No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study","volume":"15","author":"Becker","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-5-5","article-title":"Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure","volume":"5","author":"Essebag","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/oem.56.1.67","article-title":"A relative power table for nested matched case-control studies","volume":"56","author":"Pang","year":"1999","journal-title":"Occup. Environ. Med."},{"issue":"3","key":"10.1016\/j.ghir.2022.101484_bb0235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-20-0795","article-title":"Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study","volume":"184","author":"Albertelli","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101484_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5217\/ir.2014.12.2.139","article-title":"Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?","volume":"12","author":"Cho","year":"2014","journal-title":"Intestinal research"},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/phar.1334","article-title":"Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study","volume":"34","author":"Lin","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ghir.2022.101484_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/met.2010.0026","article-title":"Metformin treatment for small benign thyroid nodules in patients with insulin resistance","volume":"9","author":"Rezz\u00f3nico","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637422000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637422000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:46Z","timestamp":1761087166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637422000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":48,"alternative-id":["S1096637422000417"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2022.101484","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2022.101484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101484"}}